• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Johnson & Johnson (NY:JNJ)

    205.80 -1.15 (-0.56%)
    Streaming Delayed Price Updated: 10:20 AM EST, Jan 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,242,819
    Open 206.82
    Bid (Size) 205.74 (100)
    Ask (Size) 205.86 (500)
    Prev. Close 206.95
    Today's Range 203.68 - 206.90
    52wk Range 140.68 - 215.19
    Shares Outstanding 2,628,679,824
    Dividend Yield 2.53%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026
    From Johnson & Johnson
    Via Business Wire
    News headline image
    Johnson & Johnson Near Year High ↗
    Johnson & Johnson is nearing its 52-week high, driven by strong momentum and positive news, raising expectations for its upcoming earnings report amidst heightened sensitivity to market trends. 
    Via Talk Markets

    Performance

    YTD
    N/A
    N/A
    1 Month
    +0.2%
    +0.2%
    3 Month
    +10.7%
    +10.7%
    6 Month
    +31.9%
    +31.9%
    1 Year
    +42.9%
    +42.9%

    More News

    Read More
    News headline image
    Want Decades of Passive Income? 2 Stocks to Buy Right Now ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
    Via MarketMinute
    Topics Economy Intellectual Property Law Enforcement
    News headline image
    S&P 500 Eyes 7,000 Milestone: Technical Breakout Sets the Stage for a High-Stakes 2026
    Via MarketMinute
    Topics Artificial Intelligence Economy Energy
    News headline image
    Palantir Shares Retreat to $180.80 as Hawkish Fed Minutes and Institutional Rebalancing Cool Year-End Rally
    Via MarketMinute
    Topics Artificial Intelligence Economy
    News headline image
    The Trillion-Dollar Shuffle: How Year-End Institutional Rebalancing is Fueling Late-December Volatility
    Via MarketMinute
    Topics Artificial Intelligence Bonds ETFs
    News headline image
    The Great Consolidation: Why 2026 is Set to Become the Year of the Mega-Deal
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Hunterbrook Capital Bets Big on Achieve Life Sciences: Why a 'Toxic Tree' Could Disrupt the Multi-Billion Dollar Smoking Cessation Market
    Via MarketMinute
    Topics Product Recall
    News headline image
    The S&P 500 Seesaw: Analyzing IVV’s Year-End Turbulence After a Record-Breaking 2025
    Via MarketMinute
    Topics ETFs Economy Retirement
    News headline image
    Wall Street Stumbles at the Finish Line: S&P 500 and Nasdaq Fight to Break 3-Day Slide Amid Year-End Rebalancing
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    News headline image
    The 2026 Income Fortress: Why Big Pharma is the Defensive Play of the New Year
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever ↗
    Via The Motley Fool
    Topics Economy Intellectual Property
    News headline image
    Could These 3 "Recession-Proof" Dividend Stocks Surge 100% by 2031? ↗
    Via The Motley Fool
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    The Santa Claus Stumble: Markets Pivot from Record Highs to Year-End Consolidation
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    News headline image
    The Price of Prosperity: Navigating the S&P 500’s Historic Valuation Peak as 2026 Dawns
    Via MarketMinute
    Topics Artificial Intelligence Bonds Earnings
    News headline image
    Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies
    From Johnson & Johnson
    Via Business Wire
    News headline image
    Blue-Chip Bull Run: Dow Jones Eyes 50,000 Milestone Amidst 2026 Technical Pivot
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    News headline image
    The 2025 Growth Postgame: Analyzing the AI Supercycle and Preparing for the 2026 'Agentic' Pivot
    Via MarketMinute
    Topics Artificial Intelligence Economy World Trade
    News headline image
    Johnson & Johnson Terminates Experimental Eczema Drug Study After It Fails To Show Benefit ↗
    Via Stocktwits
    News headline image
    Johnson & Johnson Halts Atopic Dermatitis Study After Interim Analysis Miss ↗
    Via Benzinga
    News headline image
    Baxter International (BAX) in 2025: A Deep Dive into the Transformation of a MedTech Giant
    Via PredictStreet
    Topics Economy Emissions Product Recall
    News headline image
    Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
    Via MarketMinute
    Topics Economy Intellectual Property
    News headline image
    Barking Back: Why the 'Dogs of the Dow' 4-Stock Play is the Contrarian Bet for 2026
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    This Dividend ETF Could Quietly Make You a Multimillionaire Over Time ↗
    Via The Motley Fool
    Topics ETFs

    Frequently Asked Questions

    Is Johnson & Johnson publicly traded?
    Yes, Johnson & Johnson is publicly traded.
    What exchange does Johnson & Johnson trade on?
    Johnson & Johnson trades on the New York Stock Exchange
    What is the ticker symbol for Johnson & Johnson?
    The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
    What is the current price of Johnson & Johnson?
    The current price of Johnson & Johnson is 205.80
    When was Johnson & Johnson last traded?
    The last trade of Johnson & Johnson was at 01/02/26 10:20 AM ET
    What is the market capitalization of Johnson & Johnson?
    The market capitalization of Johnson & Johnson is 540.98B
    How many shares of Johnson & Johnson are outstanding?
    Johnson & Johnson has 541B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.